Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
- 24 February 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 11 (4), 2521-2532
- https://doi.org/10.1021/pr201223p
Abstract
Our understanding of the mechanisms by which nonalcoholic fatty liver disease (NAFLD) progresses from simple steatosis to steatohepatitis (NASH) is still very limited. Despite the growing number of studies linking the disease with altered serum metabolite levels, an obstacle to the development of metabolome-based NAFLD predictors has been the lack of large cohort data from biopsy-proven patients matched for key metabolic features such as obesity. We studied 467 biopsied individuals with normal liver histology (n = 90) or diagnosed with NAFLD (steatosis, n = 246; NASH, n = 131), randomly divided into estimation (80% of all patients) and validation (20% of all patients) groups. Qualitative determinations of 540 serum metabolite variables were performed using ultraperformance liquid chromatography coupled to mass spectrometry (UPLC–MS). The metabolic profile was dependent on patient body-mass index (BMI), suggesting that the NAFLD pathogenesis mechanism may be quite different depending on an individual’s level of obesity. A BMI-stratified multivariate model based on the NAFLD serum metabolic profile was used to separate patients with and without NASH. The area under the receiver operating characteristic curve was 0.87 in the estimation and 0.85 in the validation group. The cutoff (0.54) corresponding to maximum average diagnostic accuracy (0.82) predicted NASH with a sensitivity of 0.71 and a specificity of 0.92 (negative/positive predictive values = 0.82/0.84). The present data, indicating that a BMI-dependent serum metabolic profile may be able to reliably distinguish NASH from steatosis patients, have significant implications for the development of NASH biomarkers and potential novel targets for therapeutic intervention.Keywords
This publication has 43 references indexed in Scilit:
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Association of Lipidome Remodeling in the Adipocyte Membrane with Acquired Obesity in HumansPLoS Biology, 2011
- Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesityNature, 2011
- Plasma metabolomic profile in nonalcoholic fatty liver diseaseMetabolism, 2011
- The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysisEuropean Radiology, 2010
- Liquid Chromatography−Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver DiseaseJournal of Proteome Research, 2010
- Fatty Acids, Insulin Resistance, and Protein MetabolismJournal of Clinical Endocrinology & Metabolism, 2009
- Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injuryJournal Of Physiology-London, 2009
- Liver biopsyHepatology, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005